Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
Clinical trial NCT02655458 · COMPLETED
Trial details
- NCT number
- NCT02655458
- Sponsor
- Hearn Jay Cho
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-07-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.